Nuedexta is the only FDA approved drug to treat pseudobulbar affect (PBA), a rare disorder affecting less than one percent of the population, according to a CNN investigation.
The Centers for Medicare & Medicaid Services and the U.S. government is now warning insurers to be aware of unethical uses of the drug. It has had an...
